Senators Propose Sweeping Changes to Generic Drug Oversight

Lawmakers at the helm of the Senate Special Committee on Aging have proposed a sweeping series of changes that could transform the way the government safeguards the quality of essential generic drugs.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.